TY  - JOUR

T1  - Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)

JO  - Journal of the American Society of Nephrology

PY  - 2021/10/01

AU  - Lee MM

AU  - Allwood-Spiers S

AU  - Barrientos PH

AU  - Wetherall K

AU  - Mcconnachie A

AU  - Welsh P

AU  - Roditi G

AU  - Sourbron S

AU  - Radjenovic A

AU  - McMurray J

AU  - Jhund P et al

ED  - 

DO  - DOI: 10.1681/asn.20213210s1b12a

VL  - 32

IS  - 10S

SP  - b12

EP  - b12

Y2  - 2024/12/22

ER  -